Continuous Glucose Monitoring (CGM) Systems Market Size worth USD 31.70 billion by 2031: Growth Opportunities, Emerging Innovations, and Competitive

Allied Market Research has published a study report with the title Continuous Glucose Monitoring (CGM) Systems Market Size accounted for 𝐔𝐒𝐃 𝟔.𝟔𝟐 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟏, and it is estimated to surpass around 𝐔𝐒𝐃 𝟑𝟏.𝟕𝟎 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟏, registering a 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟏𝟕% from 2022 to 2031.

Continuous Glucose Monitoring (CGM) Systems are medical devices that are used to monitor glucose levels in people with diabetes. CGM systems consist of a small sensor that is inserted under the skin, usually on the abdomen or upper arm and a transmitter that sends glucose readings wirelessly to a receiver or a smartphone app. The sensor measures glucose levels in the interstitial fluid, which is the fluid that surrounds cells in the body. The transmitter sends this information to the receiver or app, which displays the glucose levels in real time. Some CGM systems also provide alerts when glucose levels are too high or too low.

Impact of Covid-19 on Continuous Glucose Monitoring Systems Market-

• Increase in demand from healthcare workers for safer ways to monitor hospitalized diabetes patients with COVID-19 impacted the global continuous glucose monitoring systems market positively.
• FDA had encouraged manufacturers to supply continuous glucose monitoring (CGM) systems for use in the hospital setting during the global health crisis. This way, the frontline healthcare workers in hospitals were able to monitor diabetic patients remotely

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐇𝐞𝐫𝐞: https://www.alliedmarketresearch.com/request-sample/1795

𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐟𝐚𝐜𝐭𝐨𝐫𝐬 𝐚𝐧𝐝 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐜𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐠𝐥𝐮𝐜𝐨𝐬𝐞 𝐦𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 (𝐂𝐆𝐌) 𝐦𝐚𝐫𝐤𝐞𝐭?

The driving factors and opportunities for growth in the global continuous glucose monitoring (CGM) market include:

• Rising incidence of diabetes: The increasing prevalence of diabetes worldwide is one of the major factors driving the growth of the CGM market. According to the International Diabetes Federation, the global prevalence of diabetes is expected to rise from 463 million in 2019 to 700 million by 2045.
• Technological advancements: The development of advanced CGM systems, such as those with improved accuracy, longer sensor life, and better connectivity, is fueling the growth of the market.
• Increasing adoption of CGM by healthcare professionals: As healthcare professionals become more aware of the benefits of CGM in diabetes management, the adoption of CGM is expected to increase.
• Growing demand for minimally invasive glucose monitoring devices: CGM systems are minimally invasive and provide continuous glucose monitoring, which makes them more convenient for patients than traditional fingerstick glucose monitoring.
• Expansion of reimbursement coverage: As more insurance companies and healthcare systems provide coverage for CGM systems, the adoption of these devices is expected to increase.

Overall, the global CGM market is expected to continue to grow in the coming years due to the increasing incidence of diabetes and the demand for advanced diabetes management solutions.

𝐓𝐨𝐩 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐆𝐥𝐮𝐜𝐨𝐬𝐞 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬

• DexCom Inc.
• Johnson & Johnson
• Novo Nordisk A/S
• F. Hoffman-La Roche Ltd
• Abbott Laboratories
• GlySens Incorporated
• Medtronic plc
• Ypsomed AG
• Senseonics
• Menarini Diagnostics S.R.L.

𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐆𝐥𝐮𝐜𝐨𝐬𝐞 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐜𝐚𝐧 𝐛𝐞 𝐝𝐨𝐧𝐞 𝐛𝐚𝐬𝐞𝐝 𝐨𝐧 𝐬𝐞𝐯𝐞𝐫𝐚𝐥 𝐟𝐚𝐜𝐭𝐨𝐫𝐬, 𝐢𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠:

By Demography

• Child Population
• Adult Population

By End User

• Home healthcare
• Others
• Hospital and Clinics

By Component

• Transmitters and Receivers
• Sensors

By region, North America garnered the highest share in 2021, contributing to nearly half of the global continuous glucose monitoring systems market revenue. This is attributed to the higher adoption of advanced CGMs, surge in the geriatric population suffering from diabetes, availability of well-developed healthcare infrastructure, and increase in the prevalence of type 2 diabetes across the world.

Asia-Pacific, simultaneously, would showcase the fastest CAGR of 17.9% from 2022 to 2031. High prevalence of the diabetic population in India, improvement in healthcare awareness, and rise in R&D activities for developing innovative CGM systems fuel the growth of the market.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/1795

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

By Region Outlook

• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐃𝐞𝐭𝐚𝐢𝐥𝐬:

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.